McDonald KL - Search Results

1

How immunotherapies are targeting the glioblastoma immune environment.

Felthun J, Reddy R, McDonald KL. Felthun J, et al. Among authors: mcdonald kl. J Clin Neurosci. 2018 Jan;47:20-27. doi: 10.1016/j.jocn.2017.10.019. Epub 2017 Oct 15. J Clin Neurosci. 2018. PMID: 29042147 Review.

2

Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma.

Parkinson JF, Wheeler HT, McDonald KL. Parkinson JF, et al. Among authors: mcdonald kl. J Clin Neurosci. 2008 Jan;15(1):1-8. doi: 10.1016/j.jocn.2007.06.005. Epub 2007 Nov 26. J Clin Neurosci. 2008. PMID: 18037296 Review.

3

Post-contrast enhancement as a clinical indicator of prognosis in patients with anaplastic astrocytoma.

Matar E, Cook RJ, Fowler AR, Biggs MT, Little NS, Wheeler HR, Robinson BG, McDonald KL. Matar E, et al. Among authors: mcdonald kl. J Clin Neurosci. 2010 Aug;17(8):993-6. doi: 10.1016/j.jocn.2009.12.015. Epub 2010 Jun 3. J Clin Neurosci. 2010. PMID: 20605464

4

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.

Tabone T, Abuhusain HJ, Nowak AK; Australian Genomics and Clinical Outcome of Glioma (AGOG) Network; Erber WN, McDonald KL. Tabone T, et al. Among authors: mcdonald kl. J Clin Pathol. 2014 Jul;67(7):550-5. doi: 10.1136/jclinpath-2014-202173. Epub 2014 Apr 2. J Clin Pathol. 2014. PMID: 24695838

5

Incorporation of biomarkers in phase II studies of recurrent glioblastoma.

Jue TR, Hovey E, Davis S, Carleton O, McDonald KL. Jue TR, et al. Among authors: mcdonald kl. Tumour Biol. 2015 Jan;36(1):153-62. doi: 10.1007/s13277-014-2960-3. Epub 2014 Dec 23. Tumour Biol. 2015. PMID: 25534238 Review.

6

The challenges associated with molecular targeted therapies for glioblastoma.

Jue TR, McDonald KL. Jue TR, et al. Among authors: mcdonald kl. J Neurooncol. 2016 May;127(3):427-34. doi: 10.1007/s11060-016-2080-6. Epub 2016 Feb 22. J Neurooncol. 2016. PMID: 26900075 Review.

7

Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma.

Sinnadurai M, McDonald KL. Sinnadurai M, et al. Among authors: mcdonald kl. J Neurooncol. 2017 May;132(3):359-372. doi: 10.1007/s11060-017-2390-3. Epub 2017 Mar 14. J Neurooncol. 2017. PMID: 28293764 Review.

8

The current evidence of statin use affecting glioblastoma prognosis.

Lu VM, McDonald KL. Lu VM, et al. Among authors: mcdonald kl. J Clin Neurosci. 2017 Aug;42:196-197. doi: 10.1016/j.jocn.2017.04.036. Epub 2017 May 8. J Clin Neurosci. 2017. PMID: 28495423

9

Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: A systematic review and meta-analysis.

Lu VM, Jue TR, Phan K, McDonald KL. Lu VM, et al. Among authors: mcdonald kl. Clin Neurol Neurosurg. 2018 Jan;164:75-80. doi: 10.1016/j.clineuro.2017.11.015. Epub 2017 Dec 1. Clin Neurol Neurosurg. 2018. PMID: 29202377

10

Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis.

Phan K, Ng W, Lu VM, McDonald KL, Fairhall J, Reddy R, Wilson P. Phan K, et al. Among authors: mcdonald kl. World Neurosurg. 2018 Mar;111:e539-e545. doi: 10.1016/j.wneu.2017.12.112. Epub 2017 Dec 27. World Neurosurg. 2018. PMID: 29288860 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters